Thus, the aim of this research work was to unravel the potential effects of gut peptide hormones on human AT by characterizing the effects of GLP-1, GIP and glucagon on VAT exometabolomic profiles pertaining to individuals with obesity across different glycemic statuses. The gene discussed is GIP; the disease is obesity disorder.